When stocks move with unusual volume, it can signal insider buying and selling.
Here's a technical look at how to trade a number of stocks rising with unusual volume flow.
Both it and Ligand Pharmaceuticals look significantly undervalued relative to their prospects.
Retrophin announced positive results from a study in which patients with a rare kidney disease responded to treatment with its experimental drug sparsentan.
©1996-2017 TheStreet, Inc. All rights reserved.Action Alerts PLUS is a registered trademark of TheStreet, Inc.